Q1 2019 January-March Business review President and CEO Hannu - - PowerPoint PPT Presentation

q1
SMART_READER_LITE
LIVE PREVIEW

Q1 2019 January-March Business review President and CEO Hannu - - PowerPoint PPT Presentation

Q1 2019 January-March Business review President and CEO Hannu Martola 26 April 2019 3.9 M 16.7 % 23.1 M 19.3 % Q1 2019 EBIT (3.7) EBIT-% (19.4) net sales(19.3) net sales change-% (2.4) 2 26/4/2019 DETECTION TECHNOLOGY PLC


slide-1
SLIDE 1

Q1

President and CEO Hannu Martola 26 April 2019

2019

January-March

Business review

slide-2
SLIDE 2

2

3.9M€

EBIT (3.7)

19.3%

net sales change-% (2.4)

16.7%

EBIT-% (19.4)

23.1M€

net sales(19.3)

26/4/2019 DETECTION TECHNOLOGY PLC BUSINESS REVIEW JANUARY-MARCH 2019

Q1 2019 ›

slide-3
SLIDE 3

3 26/4/2019 DETECTION TECHNOLOGY PLC BUSINESS REVIEW JANUARY-MARCH 2019

Q1 2019 ›

Back on track for double-digit growth Sales were driven by customer-specific CT demand especially from China SBU sales up 23% due to good demand and competitive position on security CT, market

  • pening up also in the US and Europe

MBU sales up 14% due to well-developed medical CT demand from key customers Operating profit improved although investments in R&D increased by 28%

slide-4
SLIDE 4

NET SALES BY QUARTER

4

(EUR 1,000)

26/4/2019 DETECTION TECHNOLOGY PLC BUSINESS REVIEW JANUARY-MARCH 2019

+19.3%

(YOY)

5,000 10,000 15,000 20,000 25,000 30,000 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 2016 2017 2018 2019

slide-5
SLIDE 5

OPERATING PROFIT

5

(EUR 1,000) 14.9 % 18.3 % 21.4 % 22.3 % 19.6 % 20.3 % 22.9 % 25.4 % 19.4 % 21.4 % 21.0 % 19.2 % 16.7 % 0% 5% 10% 15% 20% 25% 30% 1,000 2,000 3,000 4,000 5,000 6,000 7,000 8,000 Q116 Q216 Q316 Q416 Q117 Q217 Q317 Q417 Q118 Q218 Q318 Q418 Q119 EBIT excluding NRI (EUR 1,000) EBIT-% excluding NRI Mid-term EBIT-target ≥15%

26/4/2019 DETECTION TECHNOLOGY PLC BUSINESS REVIEW JANUARY-MARCH 2019

slide-6
SLIDE 6

SALES SPLIT

63% 37%

6

SBU

14.5 NET SALES M€ 22.9% YOY CHANGE-%

MBU

NET SALES M€ 8.6

YOY CHANGE-% 13.8%

NET SALES

23.1

M€

26/4/2019 DETECTION TECHNOLOGY PLC BUSINESS REVIEW JANUARY-MARCH 2019

BY BUSINESS UNIT ›

62% 16% 22%

NET SALES

23.1

M€

+46%

  • 27%

+15% YOY CHANGE-% ASIA AMERICAS EUROPE

BY REGION ›

slide-7
SLIDE 7

7 26/4/2019 DETECTION TECHNOLOGY PLC BUSINESS REVIEW JANUARY-MARCH 2019

(EUR 1,000) 1-3 2019 1-3 2018 1-12 2018 Net sales

23,053 19,318 93,916

Change in net sales, %

19.3% 2.4% 5.5%

Operating profit

3,855 3,741 18,522

Operating margin, %

16.7% 19.4% 19.7%

R&D costs

2,499 1,948 8,839

R&D costs, % of net sales

10.8% 10.1% 9.4%

Cash flow from operating activities

5,047 5,205 6,122

Capital expenditure

707 960 4,741

Earnings per share, EUR

0.25 0.21 1.03

KEY FIGURES

slide-8
SLIDE 8

8 26/4/2019 DETECTION TECHNOLOGY PLC BUSINESS REVIEW JANUARY-MARCH 2019

STRATEGY

Focused on SOP (start of production) of new detector solutions Received good customer feedback on pilot deliveries of Aurora, which will have an impact on SBU sales by end of 2019 Made the first customer shipments of X-Panel CMOS flat panel detectors Completed succesfully MultiX integration, started industrialization of multi energy technology Decided to establish a new production and service site to Wuxi

slide-9
SLIDE 9

5%

MEDICAL MARKET

annual growth rate

6%

SECURITY MARKET

annual growth rate

5%

INDUSTRIAL MARKET

annual growth rate

BUSINESS OUTLOOK

9

ASIA-PACIFIC IS THE FASTEST GROWING MARKET

  • Estimates sales to increase in both businesses and to achieve double-digit

revenue growth in Q2

  • Expects H2 demand to decline in MBU
  • Despite this expects total net sales to grow in H2
  • Uncertainty on demand and competition might be reflected in product prices

26/4/2019 DETECTION TECHNOLOGY PLC BUSINESS REVIEW JANUARY-MARCH 2019

slide-10
SLIDE 10

10 26/4/2019 DETECTION TECHNOLOGY PLC BUSINESS REVIEW JANUARY-MARCH 2019

FINANCIAL TARGETS UNCHANGED

MEDIUM TERM

Annual sales growth

>15%

MEDIUM TERM

Operating margin

≥15%

ANNUAL

Dividend or returned capital

30-60%

slide-11
SLIDE 11

26/04/2019 CONFIDENTIAL | Presentation name / Author 11